CDC/ACIP [U.S.] [to 2 Oct 2021]
http://www.cdc.gov/media/index.html
https://www.cdc.gov/vaccines/acip/index.html
Latest News Releases, Announcements
CDC Statement on Pregnancy Health Advisory
Wednesday, September 29, 2021
Today, CDC issued an urgent health advisory to increase COVID-19 vaccination among people who are pregnant, recently pregnant (including those who are lactating), who are trying to become pregnant now, or who might become pregnant in the future to prevent serious illness, deaths, and adverse pregnancy outcomes.
The CDC health advisory strongly recommends COVID-19 vaccination either before or during pregnancy because the benefits of vaccination for both pregnant persons and their fetus or infant outweigh known or potential risks. Additionally, the advisory calls on health departments and clinicians to educate pregnant people on the benefits of vaccination and the safety of recommended vaccines.
According to CDC data, only 31 percent of pregnant people have been vaccinated against COVID-19 and vaccination rates vary markedly by race and ethnicity. Vaccination coverage is highest among Asian people who are pregnant (45.7 percent), but lower among Hispanic or Latino pregnant people (25 percent), and lowest among Black pregnant people (15.6 percent)…

Next ACIP Meetings
No registration is required to watch the webcast.
:: October 20-21, 2021 – No agenda posted at 2 Oct 2021

MMWR News Synopsis Friday, October 1, 2021
Selected Content
:: Progress Toward Poliomyelitis Eradication — Pakistan, January 2020–July 2021
:: Disparities in COVID-19 Vaccination Status, Intent, and Perceived Access for Noninstitutionalized Adults, by Disability Status — National Immunization Survey Adult COVID Module, United States, May 30–June 26, 2021
:: Association Between K–12 School Mask Policies and School-Associated COVID-19 Outbreaks — Maricopa and Pima Counties, Arizona, July–August 2021
:: COVID-19–Related School Closures and Learning Modality Changes — United States, August 1–September 17, 2021
:: Pediatric COVID-19 Cases in Counties With and Without School Mask Requirements — United States, July 1–September 4, 2021
:: Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021

Coronavirus Disease 2019 (COVID-19)– CDC
Approximately 25 announcements/reports/data summaries.

Africa CDC [to 2 Oct 2021]
http://www.africacdc.org/
News
Statement on UK travel restrictions, September 24, 2021
28 September 2021
The Africa Centres for Disease Control and Prevention (Africa CDC), a Specialised Technical Institution of the African Union, noted with deep concern the planned changes to international travel rules in the context of the COVID-19 pandemic, communicated by the Government of the United Kingdom (U.K), which will be enforced starting at 4:00 am on Monday 4th October 2021.
According to U.K government sources1, the new rules will discriminate between the recipients of COVID-19 vaccines not based on the vaccine received but on the region in which these vaccines were received. Travellers whose vaccination is not recognised based on where they received the vaccines, including but not limited to the African Union Member States, will have to take additional measures resulting in a significant financial and social burden. These extra measures include two additional tests (pre-departure and “day 8 test” and quarantine for ten days. The sources provide no further explanation and rational behind this new rules.
The restrictions will therefore apply to persons having received vaccines through the COVAX programme, of which the U.K is one of the largest supporters, with over USD 700 million as well as 80 million vaccine doses pledged to the programme. The COVAX supplies constitute almost half of the COVID-19 vaccines supplied to the African continent to date.
We are deeply concerned that policies and rules such as this carry a risk of deepening vaccines hesitancy across Africa and creates distrust in the community…

China CDC http://www.chinacdc.cn/en/

National Health Commission of the People’s Republic of China [to 2 Oct 2021]
http://en.nhc.gov.cn/
News
Oct 2: Daily briefing on novel coronavirus cases in China
On Oct 1, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 41 new cases of confirmed infections.

China stresses strict COVID-19 prevention during National Day holiday
2021-09-30

Booster shot plans being drawn up
2021-09-30
China is accelerating the formulation of policies and implementation guidelines for COVID-19 vaccine booster shots for key groups of people as the risk of infection from imported novel coronavirus variants remains high, a health official said on Wednesday.
Cui Gang, an official at the National Health Commission, said the commission will guide local governments to give booster shots first to people who have been fully vaccinated for six months and work in high-risk areas including airports, ports, border checkpoints and hospitals, as well as people over the age of 60…

COVID chronicle outlining WHO mission published
2021-09-30
China published a chronicle on Wednesday of its work facilitating a WHO-organized mission to study the origins of the novel coronavirus, offering a detailed look at the open and transparent way it was conducted.
The chronicle starts in July last year, when the World Health Organization and China began laying the groundwork for deepening understanding of the novel coronavirus’ origins and reached an agreement on an initial phase of the study in Wuhan, Hubei province.
It ends in late March, after a joint report was released to the public and international and Chinese members of the team held briefings about the investigation results…

National Medical Products Administration – PRC [to 2 Oct 2021]
http://english.nmpa.gov.cn/news.html
News
Over 2.206 bln COVID-19 vaccine doses administered in China
2021-09-30
Over 2.206 billion doses of COVID-19 vaccine had been administered in China as of Tuesday, data from the National Health Commission showed on Sept 29.

First China-led international standard for COVID-19 prevention and control medical devices
2021-09-30

CCDC Weekly – Weekly Reports: Current Volume (3)
2021-10-01 / No. 40
View  PDF of this issue
No new digest content identified.

::::::

Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.

Paul G. Allen Frontiers Group [to 2 Oct 2021]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
No new digest content identified.

BARDA – U.S. Department of HHS [to 2 Oct 2021]
https://www.phe.gov/about/barda/Pages/default.aspx
News
No new digest content identified.

BMGF – Gates Foundation [to 2 Oct 2021]
https://www.gatesfoundation.org/ideas/media-center
Press Releases and Statements
No new digest content identified.

Bill & Melinda Gates Medical Research Institute [to 2 Oct 2021]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

CARB-X [to 2 Oct 2021]
https://carb-x.org/
News
07.29.2021  |
CARB-X celebrates five years of progress in early-stage product development against antibiotic-resistant bacteria
CARB-X, a global non-profit partnership led by Boston University, is celebrating five years of progress in funding and supporting the development of innovative products targeting antibiotic-resistant bacteria. Since it was founded in July 2016, CARB-X has invested $361 million in non-dilutive funding to develop innovative therapeutics including new classes of antibiotics and non-traditional agents, vaccines and other preventatives such as CRISPR-phage, microbiome-modifying agents and antibodies, and rapid diagnostics.

Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 2 Oct 2021]
https://centerforvaccineethicsandpolicy.net/
News/Analysis/Statements
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.
:: [NEW] Informed Consent: A Monthly Review – October 2021 is now posted here

CEPI – Coalition for Epidemic Preparedness Innovations [to 2 Oct 2021]
http://cepi.net/
Latest News
No new digest content identified.

DARPA – Defense Advanced Research Projects Agency [to 2 Oct 2021
https://www.darpa.mil/news
News
No new digest content identified.

Duke Global Health Innovation Center [to 2 Oct 2021]
https://dukeghic.org/
Our Blog
What the Latest Global COVID-19 Summit Achieved (and missed)
WEEKLY COVID VACCINE RESEARCH UPDATE Friday, September 24, 2021

EDCTP [to 2 Oct 2021]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
News
No new digest content identified.

Emory Vaccine Center [to 2 Oct 2021]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.

European Vaccine Initiative [to 2 Oct 2021]
http://www.euvaccine.eu/
Latest News
No new digest content identified.

Fondation Merieux [to 2 Oct 2021]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.

Gavi [to 2 Oct 2021]
https://www.gavi.org/
News releases [See Milestones above for detail]
Gavi statement on the report of the independent commission on sexual exploitation and abuse
30 September 2021

Gavi Board meets to discuss routine immunisation, COVAX’s 2022 strategy
29 September 2021

Gavi progress report shows resilience in childhood vaccinations despite impact of COVID-19 pandemic
29 September 2021

GHIT Fund [to 2 Oct 2021]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
No new digest content identified.

Global Fund [to 2 Oct 2021]
https://www.theglobalfund.org/en/news/
News & Stories
News
Global Fund Welcomes Netherlands New Contribution to the Global Fight Against COVID-19
01 October 2021
The Global Fund to Fight AIDS, Tuberculosis and Malaria welcomed the decision by the Netherlands to contribute an additional €15 million to the Global Fund’s COVID-19 Response Mechanism, on top of the €12 million committed in April 2021.

Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 2 Oct 2021]
https://www.glopid-r.org/news/
22/09/2021
COVID-19: Advances and Remaining Challenges international conference opens September 29
Institut Pasteur will hold this international conference in collaboration with Inserm ANRS – Maladies infectieuses émergentes from September 29 to October 1, 2021. COVID-19 experts from around the globe will attend the event which will be broadcast live in English and held under the high patronage of the French President.
Leading researchers and clinicians will present the progress made and remaining challenges in virology, clinical presentations and management, epidemiology, and vaccinology for COVID-19. Topics to be covered include:
Viral entry and replication/neutralization
Viral persistence and Long COVID
Patient management and future treatments
Evaluation of impact of interventions
Children and SARS-CoV-2 transmission and control
Vaccine regimens and effectiveness
Why and how should we get the planet vaccinated?
Learn more & register

Hilleman Laboratories [to 2 Oct 2021]
http://www.hillemanlabs.org/
Website reports “under maintenance” at inquiry

Human Vaccines Project [to 2 Oct 2021]
http://www.humanvaccinesproject.org/
News
HVP COVID Report
Sep 30, 2021
Salim Abdool Karim: The Broken System of Vaccine Distribution
Director of the Centre for the AIDS Program of Research, South Africa
Professor of Global Health, Columbia University
HVP Editor Kristen Jill Abboud recently spoke about the distribution of COVID vaccines in South Africa with Salim Abdool Karim, a clinical infectious disease epidemiologist who heads the Centre for the AIDS Program of Research in South Africa (CAPRISA) and is a Professor of Global Health at Columbia University in New York City. Karim also serves on the Lancet COVID-19 Commission and is the former chair of the South African Ministerial Advisory Committee on COVID-19. We discussed the early setbacks in the rollout of vaccines in South Africa and the lessons this pandemic offers for future global vaccine distribution.

IAVI [to 2 Oct 2021]
https://www.iavi.org/newsroom
Latest News
September 30, 2021
IAVI applauds Biden Administration’s intent to nominate John Nkengasong as head of PEPFAR
Nkengasong was a founding leader of PEPFAR and has served on IAVI’s board since 2018.

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

ICRC [to 2 Oct 2021]
https://www.icrc.org/en/whats-new
Selected News Releases, Statements, Reports
IHL App 2.0: International humanitarian law and more in your pocket
01-10-2021 | Article

DigitHarium Month #7: Biometrics and Humanitarian Protection
For the seventh DigitHarium month, we looked at how we can make biometric data work for humanitarian organizations: what they are, how they function, what advantages they present, and what mitigation measures we need to consider to make them safer to
01-10-2021 | Article

International Day for the Total Elimination of Nuclear Weapons Statement, September 2021
Mr President of the General Assembly, Mr Secretary-General, Distinguished Colleagues,I am pleased to mark this important event to commemorate the International Day for the Total Elimination of Nuclear Weapons.
30-09-2021 | Article

Joint Statement by the UN Resident and Humanitarian Coordinator and the Heads of ICRC, OCHA, UNICEF, and WHO in Afghanistan
In the meeting, we agreed to collaborate closely together and have committed our organizations to spare no effort in our joint objective to support the existing health system in Afghanistan to ensure all people have access to the healthcare they need
29-09-2021 | Statement

IFFIm
http://www.iffim.org/
Press Releases/Announcements
No new digest content identified.

IFRC [to 2 Oct 2021]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
30/09/2021
COVID-19: IFRC calls for urgent action to tackle vaccine hesitancy in Europe amid increase in violent incidents
Budapest/Geneva, 30 September 2021 – The International Federation of Red Cross and Red Crescent Societies (IFRC) is calling for urgent action to tackle vaccine hesitancy in Europe, where there has been a worrying increase in violent incidents against COVID-19 related health infrastructure and personnel…
In addition, disinformation about vaccines’ side effects and potential risks, coupled with the introduction of ‘vaccine passes’, is sparking anger and violence, which have led to concerning incidents against medical services, media and the general public in countries including Italy, the Netherlands, the United Kingdom, Poland, Slovenia and France….

30/09/2021
Afghanistan faces collapse of health services and mass hunger
… Speaking from Kabul where he has been on a four-day official visit, Alexander Matheou, IFRC Asia Pacific Director said: “After living through decades of fleeing and fighting, Afghans now face a severe drought which has devastated food production, leaving millions hungry and destitute. We are deeply concerned that Afghanistan faces imminent collapse of health services and worsening hunger if aid and money do not flow into the country within weeks. Health financing has been cut across the country placing ever more demand on Red Crescent teams. Urgent international action is needed to support millions of people with the necessities of life as Afghanistan’s looming harsh winter threatens greater misery and hardships.”…

28/09/2021
IFRC launches emergency appeal to prepare for and respond to population movements from Afghanistan

Institut Pasteur [to 2 Oct 2021]
https://www.pasteur.fr/en/press-area
Press Documents
Press release
21.09.2021
Covid-19: study on the effectiveness of immune memory after mRNA vaccination to recognize variants of SARS-CoV-2
The teams from Henri-Mondor AP-HP hospital and Paris-Est Créteil University, Inserm, CNRS, University of Paris, within the Necker-Enfants Malades Institute, and the Institut Pasteur analyzed the capacity of the immune memory generated after mRNA vaccination to recognize and neutralize SARS-CoV-2 variants.
This work, coordinated by Prof. Matthieu Mahévas, Dr Claude-Agnès Reynaud, Prof. Jean-Claude Weill, Dr Pascal Chappert, Dr Félix Rey and Dr Pierre Bruhns, shows that people vaccinated with a messenger RNA vaccine against SARS-CoV-2 develop defenses against the Beta and Delta variants. Their immune system indeed produces memory cells capable of recognizing and neutralizing these worrisome variants. The results of this study were published on September 20, 2021 in Immunity.

IOM / International Organization for Migration [to 2 Oct 2021]
http://www.iom.int/press-room/press-releases
News – Selected
News
30 Sep 2021
UN Agencies Call for Protection Measures and a Comprehensive Regional Approach for Haitians on the Move

ISC / International Science Council [to 2 Oct 2021]
https://council.science/current/
ISC is a non-governmental organization with a unique global membership that brings together 40 international scientific Unions and Associations and over 140 national and regional scientific organizations including Academies and Research Councils.
News Press
Action for Afghan scientists and scholars
01.10.2021
The InterAcademy Partnership (IAP) and the International Science Council (ISC) express concern for Afghan scholars in Afghanistan and around the world, and call for urgent action to preserve gains made in education and research in Afghanistan in recent decades.

Blog
Science in Exile podcast series launched
30.09.2021
ISC Presents: Science in Exile features interviews with refugee and displaced scientists who share their science, their stories of displacement, and their hopes for the future. In the first episode, available now, Feras Kharrat shares his experiences as a scholar of molecular biomedicine, first in Syria, and now in Italy.

News Press
Gender Equality in Science: Inclusion and Participation of Women in Global Science Organizations
Results of two global surveys show women are still under-represented in world science. New report from the ISC, InterAcademy Partnership and Gender Insite released today.

IVAC [to 2 Oct 2021]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates; Events
No new digest content identified.

IVI [to 2 Oct 2021]
http://www.ivi.int/
IVI News & Announcements
The International Vaccine Institute, Texas Children’s Hospital, and Baylor College of Medicine partner for collaborative vaccine research
Sept. 28, 2021 – SEOUL, South Korea, and HOUSTON, Texas, USA
…The collaboration is envisioned to include: (1) exchange of scientists between institutions; (2) collaborative research in vaccine development; (3) the sharing of scholarly and scientific materials, and (4) steps toward establishing an international collaborating office of IVI in a formal academic relationship with the Section of Pediatric Tropical Medicine in the Department of Pediatrics at Baylor…

Enrollment begins for Sanofi and GSK’s Phase 3 efficacy trial of COVID-19 vaccine candidate in Nepal, led by IVI
Sept. 28, 2021
…International Vaccine Institute (IVI) will lead the clinical trial in Nepal to assess the safety, efficacy and immunogenicity of an adjuvanted recombinant-protein COVID-19 vaccine candidate
Phase 3 international clinical trial includes volunteers from several countries, including sites in the US, Asia, Africa and Latin America…

IVI’s Statement for the Global COVID-19 Summit: Ending the Pandemic and Building Back Better
… To meet these goals, IVI is partnering with over 2 dozen organizations, from the laboratory through and beyond licensure, to move multiple COVID-19 vaccine candidates from testing to impact providing the kind of evidence that will inform better policy decisions on the use of vaccines and non-pharmacologic interventions…

Johns Hopkins Center for Health Security [to 2 Oct 2021]
https://www.centerforhealthsecurity.org/news/center-news/
Center News
25 Stakeholder Groups ask Congress to Support the $16 Billion Funding Level for Pandemic Preparedness Included in the Build Back Better Act Passed by the House Energy and Commerce Committee
September 28, 2021

MSF/Médecins Sans Frontières [to 2 Oct 2021]
http://www.msf.org/
Latest [Selected Announcements]
Libya
Medical care resumes in Tripoli detention centres
Project Update 29 Sep 2021

Iraq
Tackling multidrug-resistant tuberculosis, one patient at a time
Project Update 29 Sep 2021

Syria
Northern Syria: Acute water crisis poses serious health risks
Project Update 29 Sep 2021

National Academy of Medicine – USA [to 2 Oct 2021]
https://nam.edu/programs/
Selected News/Programs
National Academy of Medicine Releases Video Encouraging Latinx/Latino(a)/Hispanic Americans to Accept the COVID-19 Vaccine
September 28, 2021
Today, the National Academy of Medicine (NAM) released a video encouraging Latinx/Latino(a)/ Hispanic Americans to get vaccinated for COVID-19. The video, which features 11 Latinx/Latino(a)/ Hispanic members of the NAM, highlights the safety and efficacy of the vaccines, reinforces their integral role in bringing families and communities back together safely, and features personal affirmations from the NAM […]

National Academy of Sciences – USA [to 2 Oct 2021]
http://www.nasonline.org/news-and-multimedia/
News
No new digest content identified.

National Vaccine Program Office – U.S. HHS [to 2 Oct 2021]
https://www.hhs.gov/vaccines/about/index.html
Upcoming Meetings/Latest Updates
No new digest content identified.

NIH [to 2 Oct 2021]
http://www.nih.gov/news-events/news-releases
News Releases
NIAID issues new awards to fund “pan-coronavirus” vaccines
September 28, 2021 — The awards are intended to fuel vaccine research for a diverse family of coronaviruses, with a primary focus on potential pandemic-causing coronaviruses, such as SARS-CoV-2.
[See COVID – U.S. above for detail]

PATH [to 2 Oct 2021]
https://www.path.org/media-center/
Press Releases
No new digest content identified.

Sabin Vaccine Institute [to 2 Oct 2021]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
Commentary to the Global COVID-19 Summit: Ending the Pandemic and Building Back Better
September 15, 2021

UNAIDS [to 2 Oct 2021]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
1 October 2021
ArtPositive—art to raise awareness around HIV-related stigma and discrimination

29 September 2021
The first but not the last: Indonesian transgender man fights for recognition

28 September 2021
Launch of advocacy explainers on western Africa model drug law

UNHCR Office of the United Nations High Commissioner for Refugees [to 2 Oct 2021]
http://www.unhcr.org/en-us/media-centre.htmlS
Selected News Releases, Announcements
UN agencies call for protection measures and a comprehensive regional approach for Haitians on the move
Joint statement by UNHCR, IOM, UNICEF, OHCHR
30 Sep 2021

Yemeni humanitarian organization wins 2021 UNHCR Nansen Refugee Award
UNHCR, the UN Refugee Agency, announces the winner of its 2021 Nansen Refugee Award. Five regional winners are also announced.
29 Sep 2021

News Comment: UNHCR echoes call for global action to resolve internal displacement
This news comment is attributable to Raouf Mazou, UNHCR’s Assistant High Commissioner for Operations
29 Sep 2021

UN: Syrian Refugees in Lebanon Struggle to Survive Amid Worst Socioeconomic Crisis in Decades
29 Sep 2021

UNICEF [to 2 Oct 2021]
https://www.unicef.org/media/press-releases
Press Releases, News Notes, Statements [Selected]
Statement
10/01/2021
UNICEF statement on Ethiopia
NEW YORK, 1 October 2021 – “The Ethiopian Government’s decision to expel the UNICEF representative in the country – along with other members of the UN leadership team – is regrettable and alarming.
“UNICEF has been present in Ethiopia for more than 60 years, working to advance and protect the rights of the most vulnerable children. As the humanitarian situation in the country deteriorates – with children bearing its biggest brunt – our work is more urgent than ever. We have full confidence in the teams working on the ground to save children’s lives, guided – as always – by the principles of impartiality, humanity, neutrality and independence. Our programmes will continue. Our one and only priority is to support the children who urgently need our help, wherever they are.”

Press release
09/30/2021
Indonesia: More than 25,000 children orphaned due to COVID-19 since the start of the pandemic
UNICEF and partners call for greater support for families and surviving caregivers to ensure children remain in family-based care.
JAKARTA, 30 September 2021 – Since the start of the pandemic, 25,430 children in Indonesia have lost one or both caregivers due to COVID-19 according to a nationwide mapping by the Ministry of Women Empowerment and Child Protection (MoWECP) and UNICEF.
The mapping finds that the majority of children (57 per cent) have lost a male caregiver, over a third (37 per cent) have lost a female caregiver, and around five per cent have lost both caregivers. Most of the children are currently being looked after by a female caregiver, some by their extended families while 114 children are unaccompanied and are not being cared for by any adult.
The loss of one or both caregivers can have a detrimental impact on the nutrition, growth and development of children and can put them at greater risk of neglect, violence and exploitation – particularly infants and young children from low-income families. Children orphaned or bereft of their caregivers often face adverse consequences, including poverty and institutionalization.
The surviving or alternative caregivers also face additional economic and mental health burdens, which often fall on women and adolescent girls and may put them at increased risk of dropping out of school.
“We continue to monitor responses given to children whose parents died due to COVID-19 from all stakeholders,” said I. Gusti Ayu Bintang Darmawati, Minister of Women’s Empowerment and Child Protection. “We will make sure that these children are protected, and their rights can be fulfilled.”…

Statement
09/30/2021
UN agencies call for protection measures and a comprehensive regional approach for Haitians on the move
Joint statement by UNHCR, IOM, UNICEF, OHCHR

Press release
09/29/2021
EU Humanitarian Airbridge helps deliver 32 tonnes of UNICEF humanitarian supplies to Afghanistan

Remarks
09/29/2021
Remarks by UNICEF Executive Director Henrietta Fore at the launch of the Global Framework for United Nations Support on Syria/Iraq Third Country National Returnees

Unitaid [to 2 Oct 2021]
https://unitaid.org/
Featured News
Unitaid statement on molnupiravir as a treatment for mild and moderate COVID-19
Geneva, 1 October 2021 – Unitaid, on behalf of partners in the Access to COVID-19 Tools (ACT) Accelerator, welcomes today’s announcement on molnupiravir, an investigational oral antiviral medicine for treatment of mild and moderate COVID-19. Interim Phase 3 clinical trial results show that molnupiravir significantly reduced the risk of hospitalization or death from COVID-19 by approximately 50 percent when given in the early stages of infection.
“Effective, simple to use, oral treatments that can avert the progression to severe illness are exactly the kind of breakthroughs we need to get the pandemic under control. Deployed alongside vaccines, such medicines could drive down hospitalizations and deaths due to COVID-19,” said Dr Philippe Duneton, Executive Director of Unitaid.
Such a treatment could fundamentally change the response to the pandemic, enabling integrated test-and-care strategies when deployed together with appropriate diagnostic tests…

Statement in remembrance of Girindre Beeharry
Geneva, 30 September 2021 – I am deeply saddened by the passing of Girindre Beeharry, who represented the Bill and Melinda Gates Foundation on Unitaid’s Board, a position he held for several years. His memory remains very much alive. I would like to pay tribute to his clear-sightedness – the sharpness of his analyses went hand-in-hand with his humanity and his sense of humour. I wish to recognize and celebrate Girindre’s commitment to global public health. Through his unwavering dedication, he enabled Unitaid to move forward and find new solutions for people who need access to prevention, diagnostics, and treatments.
On behalf of everyone at Unitaid, our deepest sympathies and our most sincere condolences to Girindre’s family and to his daughter in particular.
Dr. Philippe Duneton, Executive Director, Unitaid

Vaccine Equity Cooperative [nee Initiative] [to 2 Oct 2021]
https://vaccineequitycooperative.org/news/
News
No new digest content identified.

Vaccination Acceptance & Demand Initiative [Sabin) [to 2 Oct 2021]
https://www.vaccineacceptance.org/
Announcements
No new digest content identified.

Vaccine Confidence Project [to 2 Oct 2021]
http://www.vaccineconfidence.org/
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).

Vaccine Education Center – Children’s Hospital of Philadelphia [to 2 Oct 2021]
http://www.chop.edu/centers-programs/vaccine-education-center
News
Feature Article — Guillain-Barré Syndrome (GBS) & Vaccines: The Risks and Recommendations
Published on Sep 14, 2021

Wellcome Trust [to 2 Oct 2021]
https://wellcome.ac.uk/news
News and reports
No new digest content identified.

The Wistar Institute [to 2 Oct 2021]
https://www.wistar.org/news/press-releases
Press Releases
No new digest content identified.

WFPHA: World Federation of Public Health Associations [to 2 Oct 2021]
https://www.wfpha.org/
Latest News
Eradicating Polio: What more Is Needed?
Sep 22, 2021
Polio cases have fallen 99.9% since 1988. In 2020 Africa was certified polio free by the World Health Organization. However, polio will remain a key public health concern until such time as there are no wild… On October 12, 2021, at 10:00 – 11:00 (CEST), “Eradicating Polio: What more Is Needed?” webinar will be held to focus on the barriers, challenges and leverages to reach every child and eradicate polio globally. Register

World Bank [to 2 Oct 2021]
http://www.worldbank.org/en/news/all
Selected News, Announcements
The World Bank Provides US$ 500 Million to Strengthen Argentina’s COVID-19 Vaccination Plan
WASHINGTON D.C., October 1, 2021 – The World Bank Board of Directors today approved a US$500 million loan to strengthen Argentina’s efforts to contain the COVID-19 pandemic. The loan will be used to procure…
Date: October 01, 2021 Type: Press Release

Nigeria Scales Up its COVID-19 Vaccination with New Funding for Vaccine Purchase and Deployment
WASHINGTION, September 30, 2021 — The Government of Nigeria today received approval from The World Bank Board of Directors for a $400 million credit in additional financing from the International Development…
Date: September 30, 2021 Type: Press Release L

Development in a Time of Upheaval – World Bank Group President
Malpass outlines ways to boost growth, combat reversals in gender equality and human development, address rising inequality and climate change KHARTOUM, Sept. 30, 2021—World Bank Group President David…
Date: September 30, 2021 Type: Press Release

Development in a Time of Upheaval – Positioning Speech by World Bank Group President David Malpass
Watch the full recording of the speech.  Thank you, Prime Minister Hamdok for the warm introduction and hospitality. Ladies and gentlemen, it’s a great pleasure for me to be speaking today from Africa…
Date: September 30, 2021 Type: Speeches and Transcripts

US$100 Million to Support COVID-19 Vaccination in Iraq
BAGHDAD, September 28, 2021 — The World Bank has approved a new US$100 million project to scale up Iraq’s health sector response to the COVID-19 pandemic. The Iraq COVID-19 Vaccination Project will…
Date: September 28, 2021 Type: Press Release Language: English

World Customs Organization – WCO [to 2 Oct 2021]
http://www.wcoomd.org/
Latest News – Selected Items
01 October 2021
Members of the WCO North of Africa, Near and Middle East (MENA) region discuss challenges and solutions in the cross-border e-commerce environment

World Organisation for Animal Health (OIE) [to 2 Oct 2021]
https://www.oie.int/en/for-the-media/press-releases/2021/
Press Releases, Statements
Enhancing veterinary laboratory capacity in COVID-19’s wake through the first-ever virtual OIE PVS mission
News
28 September 2021
The COVID-19 pandemic has marked a challenging but breakthrough moment for science, research and society at large. A cornerstone of human and animal health systems, laboratories across the world have seen the continuity of their operations put to the test. Their significant engagement to enhance capacity, to conduct research and to put equipment and expertise at the disposal of the larger health system, often meant that only critical diagnostic laboratory functions were maintained and ramped up, while other types of activities had to take a back seat. Travel restrictions made access to laboratory facilities limited or nearly impossible for external stakeholders, and essential quality assurance activities, such as audits and technical training, became difficult to implement. Among these challenges was the implementation of in-country missions by the World Organisation for Animal Health (OIE).

WTO – World Trade Organisation [to 2 Oct 2021]
http://www.wto.org/english/news_e/news_e.htm
WTO News and Events
No new digest content identified.

::::::

ARM [Alliance for Regenerative Medicine] [to 2 Oct 2021]
https://alliancerm.org/press-releases/
Selected Press Releases
No new digest content identified.

BIO [to 2 Oct 2021]
https://www.bio.org/press-releases
Press Releases, Letters, Testimony, Comments [Selected]
No new digest content identified.

DCVMN – Developing Country Vaccine Manufacturers Network [to 2 Oct 2021]
http://www.dcvmn.org/
News; Upcoming events
No new digest content identified.

ICBA – International Council of Biotechnology Associations [to 2 Oct 2021]
https://internationalbiotech.org/news/
News
No new digest content identified.

IFPMA [to 2 Oct 2021]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
African research foundation partners with international pharmaceutical industry to strengthen capacity for health innovation innovation in Africa
28 September 2021, Cape Town/Geneva – H3D-Foundation (H3D-F) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) announced today a three-year partnership to strengthen capacity for health innovation in Africa. The two organizations will combine forces to focus on driving capacity strengthening for drug discovery and development in Africa by scaling existing initiatives and identifying new development opportunities for young and mid-career scientists in the region.

The COVID-19 pandemic has highlighted the urgent need to bolster Africa’s ability, including its drug innovation capabilities, to face future health emergencies. Africa only conducts approximately 2 percent of world research on new infections, despite shouldering a quarter of the global disease burden[1]. While the continent is better prepared now to contribute to new healthcare threats as they emerge compared to a few decades ago, the disease focus remains narrow and is often not fully aligned with regional priorities. According to H3D-F, a foundation established to reduce barriers for health innovation and actively support African researchers and centers within the field of drug discovery and related sciences, the continent is primed for progress but requires an integrated health innovation ecosystem, investment in robust infrastructure, technology platforms, a critical mass of skilled talent, and job creation.

“The University of Cape Town Holistic Drug Discovery & Development (H3D) centre is the only integrated drug discovery and development platform in Africa. Over the last 10 years, it has proven itself as a platform to develop world class infrastructure, talent, and health innovation that will contribute to improving lives not only in Africa, but all over the world. We are ready to take our work to the next level through partnership and collaboration with key organizations like IFPMA, strengthening capacity far beyond H3D,” said Kelly Chibale, Chairman and CEO of H3D-F and Founder and Director of H3D.

Africa now hosts over 250 research sites and 73 vaccine clinical trials, but there are many gaps to fill[2]. For example, less than 10 universities provide vaccinology courses and only two local universities engage in vaccine-related pre-clinical studies[3]. IFPMA’s role is to be an anchor partner to provide short- to mid-term support in increasing awareness of H3D-F activities to develop and strengthen the capacity of human resources for health innovation in Africa. It will facilitate networking and visibility across the innovation ecosystem through its membership and offer opportunities for collaboration from drug development to market. Shared aims of the organizations are to call attention to drug innovation and access in the region – key pillars to achieving the sustainable development goals and universal health coverage…

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

International Alliance of Patients’ Organizations – IAPO [to 2 Oct 2021]
https://www.iapo.org.uk/news/topic/6
Press and media [Selected]
No new digest content identified.

PhRMA [to 2 Oct 2021]
http://www.phrma.org/
Latest News [Selected]
No new digest content identified.

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

BMC Health Services Research
http://www.biomedcentral.com/bmchealthservres/content
(Accessed 2 Oct 2021)

Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation
Genetic testing has potential roles in identifying whether an individual would have risk of adverse drug reactions (ADRs) from a particular medicine. Robust cost-effectiveness results on genetic testing would …
Authors: Saowalak Turongkaravee, Jiraphun Jittikoon, Onwipa Rochanathimoke, Kathleen Boyd, Olivia Wu and Usa Chaikledkaew
Citation: BMC Health Services Research 2021 21:1042
Content type: Research article
Published on: 2 October 2021

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 2 Oct 2021)

Defining ethical challenge(s) in healthcare research: a rapid review
Despite its ubiquity in academic research, the phrase ‘ethical challenge(s)’ appears to lack an agreed definition. A lack of a definition risks introducing confusion or avoidable bias. Conceptual clarity is a …
Authors: Guy Schofield, Mariana Dittborn, Lucy Ellen Selman and Richard Huxtable
Citation: BMC Medical Ethics 2021 22:135
Content type: Research
Published on: 29 September 2021

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 2 Oct 2021)

Cross-cultural validation of the IRB Researcher Assessment Tool: Chinese Version
Using an effective method for evaluating Institutional Review Board (IRB) performance is essential for ensuring an IRB’s effectiveness, efficiency, and compliance with applicable human research standards and o…
Authors: Xing Liu, Ying Wu, Min Yang, Yang Li, Jessica Hahne, Kaveh Khoshnood, Linda Coleman and Xiaomin Wang
Citation: BMC Medical Ethics 2021 22:133
Content type: Research
Published on: 28 September 2021

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 2 Oct 2021)

COVID-19 underscores the important role of Clinical Ethics Committees in Africa
The COVID-19 pandemic has magnified pre-existing challenges in healthcare in Africa. Long-standing health inequities, embedded in the continent over centuries, have been laid bare and have raised complex ethic…
Authors: Keymanthri Moodley, Siti Mukaumbya Kabanda, Anita Kleinsmidt and Adetayo Emmanuel Obasa
Citation: BMC Medical Ethics 2021 22:131
Content type: Research article
Published on: 25 September 2021

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 2 Oct 2021)

Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections
This study aims to identify the causative strain of SARS-CoV-2 in a cluster of vaccine breakthroughs. Vaccine breakthrough by a highly transmissible SARS-CoV-2 strain is a risk to global public health.
Authors: Timothy Farinholt, Harsha Doddapaneni, Xiang Qin, Vipin Menon, Qingchang Meng, Ginger Metcalf, Hsu Chao, Marie-Claude Gingras, Vasanthi Avadhanula, Paige Farinholt, Charu Agrawal, Donna M. Muzny, Pedro A. Piedra, Richard A. Gibbs and Joseph Petrosino
Citation: BMC Medicine 2021 19:255
Content type: Research article
Published on: 1 October 2021

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 2 Oct 2021)

Governance structure affects transboundary disease management under alternative objectives
The development of public health policy is inextricably linked with governance structure. In our increasingly globalized world, human migration and infectious diseases often span multiple administrative jurisdictions that might have different systems of government and divergent management objectives. However, few studies have considered how the allocation of regulatory authority among jurisdictions can affect disease management outcomes.
Authors: Julie C. Blackwood, Mykhaylo M. Malakhov, Junyan Duan, Jordan J. Pellett, Ishan S. Phadke, Suzanne Lenhart, Charles Sims and Katriona Shea
Citation: BMC Public Health 2021 21:1782
Content type: Research
Published on: 2 October 2021

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 2 Oct 2021)

Patients at high risk for a severe clinical course of COVID-19 — small-area data in support of vaccination and other population-based interventions in Germany
Research has shown that the risk for a severe course of COVID-19 is increased in the elderly population and among patients with chronic conditions. The aim of this study was to provide estimates of the size of…
Authors: Jakob Holstiege, Manas K. Akmatov, Claudia Kohring, Lotte Dammertz, Frank Ng, Thomas Czihal, Dominik von Stillfried and Jörg Bätzing
Citation: BMC Public Health 2021 21:1769
Content type: Research
Published on: 28 September 2021

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 2 Oct 2021)

Population preferences and attitudes towards COVID-19 vaccination: a cross-sectional study from Pakistan
While vaccine development is itself a challenge; ensuring optimal vaccine uptake at population level can present an even more significant challenge. Therefore, this study aimed to assess the Pakistani populati…
Authors: Muhammad Junaid Tahir, Muhammad Saqlain, Waleed Tariq, Summaiya Waheed, Steven H. S. Tan, Sarim Irhas Nasir, Irfan Ullah and Ali Ahmed
Citation: BMC Public Health 2021 21:1759
Content type: Research article
Published on: 26 September 2021

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 2 Oct 2021)

Tolerability of MenACWY-TT vaccination in adolescents in the Netherlands; a cross-sectional study
In 2018, meningococcal ACWY-TT vaccine (MenACWY-TT) was offered to adolescents in the Netherlands within the National Immunization Programme at 14 years of age. A questionnaire study assessed the tolerability …
Authors: J. M. Kemmeren, L. van Balveren, A. Kant and H. de Melker
Citation: BMC Public Health 2021 21:1752
Content type: Research article
Published on: 26 September 2021

Cell
Sep 30, 2021 Volume 184 Issue 20 p5071-5260
https://www.cell.com/cell/current

Commentary
COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
Muge Cevik, Nathan D. Grubaugh, Akiko Iwasaki, Peter Openshaw
As the SARS-CoV-2 epidemic evolves, new variants continue to emerge. Some highly transmissible variants, such as Delta, also raised concerns about the effectiveness provided by current vaccines. Understanding immunological correlates of protection and how laboratory findings correspond to clinical effectiveness is imperative to shape future vaccination strategies.

Clinical Trials
Volume 18 Issue 5, October 2021
https://journals.sagepub.com/toc/ctja/18/5

Ethics
Navigating the ethics of remote research data collection
Luke Gelinas, Walker Morrell, Sarah A White, Barbara E Bierer
First Published July 7, 2021; pp. 606–614
COVID-19 has accelerated broad trends already in place toward remote research data collection and monitoring. This move implicates novel ethical and regulatory challenges which have not yet received due attention. Existing work is preliminary and does not seek to identify or grapple with the issues in a rigorous and sophisticated way. Here, we provide a framework for identifying and addressing challenges that we believe can help the research community realize the benefits of remote technologies while preserving ethical ideals and public trust. We organize issues into several distinct categories and provide points to consider in a table that can help facilitate ethical design and review of research studies using remote health instruments.

Clinical Trials
Volume 18 Issue 5, October 2021
https://journals.sagepub.com/toc/ctja/18/5

Design
Challenges and opportunities for conducting a vaccine trial during the COVID-19 pandemic in the United Kingdom
M Estée Török, Benjamin R Underwood, Mark Toshner, Claire Waddington, Emad Sidhom, Katherine Sharrocks, Rachel Bousfield, Charlotte Summers, Caroline Saunders, Zoe McIntyre, Helen Morris, Jo Piper, Gloria Calderon, Sarah Dennis, Tracy Assari, Anita Marguerie de Rotrou, Ashley Shaw, John Bradley, John O’Brien, Robert C Rintoul, Ian Smith, Ed Bullmore, Krishna Chatterjeeon behalf of the Cambridge COVID Vaccine Trial Team
First Published June 22, 2021; pp. 615–621

The European Journal of Public Health
SUPPLEMENT – Volume 31, Issue Supplement_1, July 2021
https://academic.oup.com/eurpub/issue/31/Supplement_1

Supplement: E-Mental-Health: Exploring the Evidence Base and Stakeholders’ Perspectives on Internet-Based Interventions for the Prevention of Mental Health Conditions
Mental illness represents an enormous personal, social and societal burden for European citizens1 calling for the need to expand existing models of mental healthcare delivery. In Europe, the Internet is a key source of health information,2 and technology-enhanced (psychological) interventions such as Internet- and mobile-delivered applications (‘eHealth’3 and ‘m-Health’4) have become increasingly popular and studied. There is already strong evidence of the efficacy of online interventions for the prevention and treatment of several psychological disorders5,6 and meta-analyses show effect sizes similar to face-to-face interventions.7

Expert Review of Vaccines
Vol 20 (9) 2021
https://www.tandfonline.com/toc/ierv20/current

Article
Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2
Divakar Sharma
Pages: 1051-1057
Published online: 06 Aug 2021

Expert Review of Vaccines
Vol 20 (9) 2021
https://www.tandfonline.com/toc/ierv20/current

Review
A practitioner’s guide to the recombinant zoster vaccine: review of national vaccination recommendations
Raunak Parikh, Robyn Widenmaier & Nicolas Lecrenier
Pages: 1065-1075
Published online: 01 Sep 2021

Expert Review of Vaccines
Vol 20 (9) 2021
https://www.tandfonline.com/toc/ierv20/current

Article
Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50–69 years
Xinyue Lu, Jia Lu, Liping Zhang, Kewen Mei, Baichu Guan & Yihan Lu
Pages: 1147-1152
Published online: 21 Jul 2021

Expert Review of Vaccines
Vol 20 (9) 2021
https://www.tandfonline.com/toc/ierv20/current

Article
Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh
A.B.M. Muksudul Alam, Md Anwarul Azim Majumder, Mainul Haque, Fatema Ashraf, Mohib Ullah Khondoker, Saidur Rahman Mashreky, Abrar Wahab, Tosaddeque Hossain Siddiqui, Aftab Uddin, Taufique Joarder, S.M. Moslehuddin Ahmed, Farzana Deeba, Kamrun Nessa, Sayeeda Rahman, Iffat Jahan, Zakirul Islam, Nihad Adnan, Munzur- E-Murshid, Shafiqul Islam, Umme Laila Urmi, Abdullah Yusuf, Nitai Chandra Sarkar, Taslim Sajjad Mallik, A.M. Selim Raza, A.K.M. Daud & Mohammed S. Razzaque
Pages: 1167-1175
Published online: 06 Sep 2021

Expert Review of Vaccines
Vol 20 (9) 2021
https://www.tandfonline.com/toc/ierv20/current

Article
Understanding COVID-19 vaccine acceptance in Pakistan: an echo of previous immunizations or prospect of change?
Tehniat F Ahmed, Affan Ahmed, Sheharyar Ahmed & Haadi U Ahmed
Pages: 1185-1193
Published online: 17 Aug 2021

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 2 Oct 2021]

Research Article metrics
Revised
COVID-19: Identifying countries with indicators of success in responding to the outbreak [version 2; peer review: 1 approved, 1 approved with reservations]
David S. Kennedy, VK Vu, Hannah Ritchie, Rebecca Bartlein, Oliver Rothschild, Daniel G. Bausch, Max Roser, Anna C. Seale
Peer Reviewers Richard A. Kock; Flavio Codeco Coelho
Funders – Bill and Melinda Gates Foundation, Department of Health & Social Care, Wellcome Trust
LATEST VERSION PUBLISHED 29 Sep 2021

Global Health: Science and Practice (GHSP)
Vol. 9, No. 3 September 30, 2021
http://www.ghspjournal.org/content/current

ORIGINAL ARTICLES
Open Access
Applying Adult Learning Best Practices to Design Immunization Training for Health Care Workers in Ghana
Denise Traicoff, Dieula Delissaint Tchoualeu, Joseph Opare, Melissa Wardle, Pamela Quaye, Hardeep S. Sandhu and George Bonsu
Global Health: Science and Practice September 2021, 9(3):487-497; https://doi.org/10.9745/GHSP-D-21-00090
Best practices of adult learning were used to develop a training of trainers program for the Ghana Health Service immunization workforce. The program supported translating learning to behavior change, used class time for practice-teaching and action plan development, linked formal instruction with specific activities, and offered follow-up mentorship.

Global Health: Science and Practice (GHSP)
Vol. 9, No. 3 September 30, 2021
http://www.ghspjournal.org/content/current

Open Access
Evaluation of the Impact of Immunization Second Year of Life Training Interventions on Health Care Workers in Ghana
Dieula Delissaint Tchoualeu, Bonnie Harvey, Mawuli Nyaku, Joseph Opare, Denise Traicoff, George Bonsu, Pamela Quaye and Hardeep S. Sandhu
Global Health: Science and Practice September 2021, 9(3):498-507; https://doi.org/10.9745/GHSP-D-21-00091
Applying performance-based training interventions that follow adult learning principles and include follow-up activities after training may help to solve specific performance problems and improve health care workers’ performance in immunization service delivery. These strategies facilitate learning, minimize the forgetting curve for health care workers, and should be considered as a standard practice for future training interventions.

Global Health: Science and Practice (GHSP)
Vol. 9, No. 3 September 30, 2021
http://www.ghspjournal.org/content/current

Income Inequalities in Hepatitis B Vaccination and Willingness to Pay Among Women of Reproductive Age in Hanoi, Vietnam
Xuan Thi Thanh Le, Nguyen Thao Thi Nguyen, Huong Thi Le, Toan Thanh Thi Do, Thang Huu Nguyen, Huong Lan Thi Nguyen, Trang Ha Nguyen, Linh Gia Vu, Bach Xuan Tran, Carl A. Latkin, Cyrus S.H. Ho and Roger C.M. Ho
Global Health: Science and Practice September 2021, 9(3):523-531; https://doi.org/10.9745/GHSP-D-20-00480
Many countries use a fee-for-service model for hepatitis B vaccination, which amplifies health disparities across socioeconomic statuses and contributes to inequalities in HBV vaccination rates. We examined the role of household income on women’s willingness to pay and the amount they are willing to pay for HBV vaccination to identify a more optimized payment scheme and equitable access across all income groups.

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 2 Oct 2021]

COVID-19: Factors associated with psychological distress, fear, and coping strategies among community members across 17 countries
The current pandemic of COVID-19 impacted the psychological wellbeing of populations globally.
Authors: Muhammad Aziz Rahman, Sheikh Mohammed Shariful Islam, Patraporn Tungpunkom, Farhana Sultana, Sheikh M. Alif, Biswajit Banik, Masudus Salehin, Bindu Joseph, Louisa Lam, Mimmie Claudine Watts, Sabria Jihan Khan, Sherief Ghozy, Sek Ying Chair, Wai Tong Chien, Carlos Schönfeldt-Lecuona, Nashwa El-Khazragy…
Citation: Globalization and Health 2021 17:117
Content type: Research
Published on: 1 October 2021

Health and Human Rights
Volume 23, Issue 1, June 2021
https://www.hhrjournal.org/volume-23-issue-1-june-2021/

General Papers
PERSPECTIVE  Should COVID-19 Vaccines Authorized for Emergency Use Be Considered “Essential” Medicines?
Maxwell J. Smith, Lisa Forman, Michael Parker, Katrina Perehudoff, Belinda Rawson, and Sharifah Sekalala

Health and Human Rights
Volume 23, Issue 1, June 2021
https://www.hhrjournal.org/volume-23-issue-1-june-2021/

Is Mandatory Vaccination for COVID-19 Constitutional under Brazilian Law?
Daniel Wei Liang Wang, Gabriela Moribe, and Ana Luisa Gajardoni de M. Arruda

Health and Human Rights
Volume 23, Issue 1, June 2021
https://www.hhrjournal.org/volume-23-issue-1-june-2021/

Virtual Roundtable
Equitable COVID-19 Vaccine Access
Els Torreele and Joseph J. Amon

Human Gene Therapy
Volume 32, Issue 17-18 / September 2021
https://www.liebertpub.com/toc/hum/32/17-18

Pathways/Interview
Gene Therapy, the Immune System, and Vaccine Development: An Interview with Hildegund Ertl
Thomas Gallagher
Pages:865–867
Published Online:23 September 2021
https://doi.org/10.1089/hum.2021.29177.her

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/localisation-and-local-humanitarian-action/

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

Immunity [NEW JOURNAL ADDED]
Sep 14, 2021 Volume 54 Issue 9 p1903-2168
https://www.cell.com/immunity/issue?pii=S1074-7613(20)X0010-0

Articles
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants
Aaron J. Schmitz, et al.
SARS-CoV-2 variants with increased transmissibility are a public health threat. Schmitz et al. characterize 2C08, a human monoclonal antibody derived from a SARS-CoV-2 vaccine-induced germinal center B cell. 2C08 possesses a broad and potent neutralization capacity and protects hamsters against challenge with D614G, B.1.351, or B.1.617.2 strains. Public 2C08-like clones can be elicited by both SARS-CoV-2 infection and vaccination.

JAMA
September 28, 2021, Vol 326, No. 12, Pages 1133-1222
https://jamanetwork.com/journals/jama/currentissue

Research Letter
Myocarditis and Pericarditis After Vaccination for COVID-19
George A. Diaz, MD; Guilford T. Parsons, MD, MS; Sara K. Gering, BS, BSN; et al.
free access has active quiz
JAMA. 2021;326(12):1210-1212. doi:10.1001/jama.2021.13443
This study investigates the incidence of myocarditis and pericarditis emergency department or inpatient hospital encounters before COVID-19 vaccine availability (January 2019–January 2021) and during a COVID-19 vaccination period (February-May 2021) in a large US health care system.

JAMA
September 28, 2021, Vol 326, No. 12, Pages 1133-1222
https://jamanetwork.com/journals/jama/currentissue

Governing Human Germline Editing Through Patent Law
Jacob S. Sherkow, JD, MA; Eli Y. Adashi, MD, MS; I. Glenn Cohen, JD
JAMA. 2021;326(12):1149-1150. doi:10.1001/jama.2021.13824
This Viewpoint discusses ethical considerations and use of patents for human germline editing in the context of a recent World Health Organization report and release of several auxiliary documents exploring international governance tools for human genome engineering.

JAMA
September 28, 2021, Vol 326, No. 12, Pages 1133-1222
https://jamanetwork.com/journals/jama/currentissue

Governing Human Germline Editing Through Patent Law
Jacob S. Sherkow, JD, MA; Eli Y. Adashi, MD, MS; I. Glenn Cohen, JD
JAMA. 2021;326(12):1149-1150. doi:10.1001/jama.2021.13824
This Viewpoint discusses ethical considerations and use of patents for human germline editing in the context of a recent World Health Organization report and release of several auxiliary documents exploring international governance tools for human genome engineering.

JAMA Network
COVID-19 Update October 2, 2021

These articles on COVID-19 were published across the JAMA Network in the last week.

Journal of Community Health
Volume 46, issue 5, October 2021
https://link.springer.com/journal/10900/volumes-and-issues/46-5

Correlates of HPV Vaccination Intentions Among Adults Ages 27–45 Years Old in the U.S.
Authors (first, second and last of 6)
Erika L. Thompson
Ashvita Garg
Christopher W. Wheldon
Content type: Original Paper
Published: 13 February 2021
Pages: 893 – 902

Journal of Community Health
Volume 46, issue 5, October 2021
https://link.springer.com/journal/10900/volumes-and-issues/46-5

Factors Associated with Willingness to be Vaccinated Against COVID-19 in a Large Convenience Sample
Authors (first, second and last of 7)
Casey Dorman
Anthony Perera
Deborah DiazDeleon
Content type: Original Paper
Published: 09 April 2021
Pages: 1013 – 1019

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 2 Oct 2021]

Designing supply chains to meet the growing need of vaccines: evidence from four countries
Immunization supply chains (iSCs) move vaccines from manufacturer to point of use with the added complexities of requiring cold chain and an increasing need for agility and efficiency to ensure vaccine quality…
Authors: Wendy Prosser, Cary Spisak, Benjamin Hatch, Joseph McCord, Marie Tien and Greg Roche
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:80
Content type: Research
Published on: 29 September 2021

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 2 Oct 2021]

Impact of the first phase of COVID-19 pandemic on childhood routine immunisation services in Nepal: a qualitative study on the perspectives of service providers and users
The COVID-19 pandemic has disproportionately affected all essential healthcare services delivery in low-resource settings. This study aimed to explore the challenges and experiences of providers and users of c…
Authors: Asmita Priyadarshini Khatiwada, Smriti Maskey, Nistha Shrestha, Sunil Shrestha, Saval Khanal, Bhuvan KC and Vibhu Paudyal
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:79
Content type: Research
Published on: 29 September 2021

The Lancet
Oct 02, 2021 Volume 398 Number 10307 p1195-1278, e15
https://www.thelancet.com/journals/lancet/issue/current

Articles
Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial
Bernadette C Young, et al.
Daily contact testing of school-based contacts was non-inferior to self-isolation for control of COVID-19 transmission, with similar rates of symptomatic infections among students and staff with both approaches. Infection rates in school-based contacts were low, with very few school contacts testing positive. Daily contact testing should be considered for implementation as a safe alternative to home isolation following school-based exposures.

Lancet Respiratory Medicine
Oct 2021 Volume 9 Number 10 p1077-1202, e96-e103
https://www.thelancet.com/journals/lanres/issue/current

Comment
COVID-19 vaccines: addressing hesitancy in young people with allergies
Elissa M Abrams, Marcus Shaker, Ian Sinha, Matthew Greenhawt

Lancet Respiratory Medicine
Oct 2021 Volume 9 Number 10 p1077-1202, e96-e103
https://www.thelancet.com/journals/lanres/issue/current

Articles
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial
Tracy J Ruckwardt, get al; VRC 317 study team

Medical Decision Making (MDM)
Volume 41 Issue 7, October 2021
http://mdm.sagepub.com/content/current

Editorials
The International Patient Decision Aid Standards (IPDAS) Collaboration: Evidence Update 2.0
Dawn Stacey, Robert J. Volk, for the IPDAS Evidence Update Leads (Hilary Bekker, Karina Dahl Steffensen, Tammy C. Hoffmann, Kirsten McCaffery, Rachel Thompson, Richard Thomson, Lyndal Trevena, Trudy van der Weijden, and Holly Witteman)
First Published August 20, 2021; pp. 729–733

Nature
Volume 597 Issue 7878, 30 September 2021
https://www.nature.com/nature/volumes/597/issues/7878

World View | 23 September 2021
The incoming Afghan government must allow immunizations
The world must work with Kabul’s new rulers to get polio and other diseases under control.
Zulfiqar A. Bhutta

New England Journal of Medicine
September 30, 2021 Vol. 385 No. 14
http://www.nejm.org/toc/nejm/medical-journal

Perspective
Marking the 40th Anniversary of the AIDS Epidemic — American Physicians Look Back R. Bayer, G.M. Oppenheimer, and V. Parisi

PLoS Biology
https://journals.plos.org/plosbiology/
(Accessed 2 Oct 2021)

Perspective
Twenty steps to ingrain power asymmetry in global health biomedical research
Iruka N. Okeke
| published 30 Sep 2021 PLOS Biology
https://doi.org/10.1371/journal.pbio.3001411
Health research in low-income settings must prioritize sustainability to truly impact target diseases in the long term. Here, I satirically summarize how biomedical investigators from high-income countries can collaboratively work to (not) accomplish this.

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 2 Oct 2021)

COVID-19 and global equity for health: The good, the bad, and the wicked
Elvin H. Geng, Michael J. A. Reid, Eric Goosby, Quarraisha Abdool-Karim
Perspective | published 01 Oct 2021 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003797